9DC2 の概要
| エントリーDOI | 10.2210/pdb9dc2/pdb |
| EMDBエントリー | 46740 |
| 分子名称 | Capsid protein (1 entity in total) |
| 機能のキーワード | parvoviridae, aav vector, capsid, adeno-associated virus, virus |
| 由来する生物種 | adeno-associated virus 8 |
| タンパク質・核酸の鎖数 | 60 |
| 化学式量合計 | 3596633.46 |
| 構造登録者 | |
| 主引用文献 | Mietzsch, M.,Kamat, M.,Basso, K.,Chipman, P.,Huiskonen, J.T.,McKenna, R. Structural characterization and epitope mapping of the AAVX affinity purification ligand. Mol Ther Methods Clin Dev, 32:101377-101377, 2024 Cited by PubMed Abstract: The application of adeno-associated virus (AAV) vectors in human gene therapies requires reproducible and homogeneous preparations for clinical efficacy and safety. For the AAV production process, often scalable affinity chromatography columns are utilized, such as the POROS CaptureSelect AAVX affinity resin, during downstream processing to ensure highly purified AAV vectors. The AAVX ligand is based on a camelid single-domain antibody capturing a wide range of recombinant AAV capsids. Described here is the identification of the AAV8 capsid epitope to AAVX at 2.3 Å resolution using cryo-electron microscopy. The ligand binds near the 5-fold axis of the capsid in a similar manner to the previously characterized AVB affinity ligand but does not conform to the capsid's icosahedral symmetry. The cross-reactivity of AAVX to other AAV capsids is achieved by primarily interacting with the peptide backbone of the AAV capsid's structurally conserved DE and HI loops. These observations will guide AAV capsid engineering efforts to retain the ability of future recombinant capsid designs to be purified using antibody-based affinity ligands. PubMed: 39677563DOI: 10.1016/j.omtm.2024.101377 主引用文献が同じPDBエントリー |
| 実験手法 | ELECTRON MICROSCOPY (2.41 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード
をダウンロード
